[New oral antidiabetic agents and current strategies of peroral antidiabetic therapy (PAD)].
Optimal compensation in patients with type 2 diabetes is individualization of therapy according to the stage of the disease and ratio of the main pathophysiological disorders. Because of the hitherto inadequate effectiveness of known procedures attention is focused on seeking new more effective procedures either based on the use of known molecules of oral antidiabetics or introduction of new substances.
Interní klinika IPVZ Praha se sídlem v Bat'ovĕ nemocnici, Zlín.
J
J
Rybka
M
M
Kvapil
D000284:Administration, Oral; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism; D004338:Drug Combinations; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics
D004338:Drug Combinations; D007004:Hypoglycemic Agents